• Something wrong with this record ?

Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome

LK. Krčmová, L. Javorská, K. Matoušová, P. Šmahel, M. Skála, M. Kopecký, C. Suwanvecho, N. Přívratská, D. Turoňová, B. Melichar

. 2024 ; 62 (6) : 1217-1227. [pub] 20240221

Language English Country Germany

Document type Journal Article

OBJECTIVES: Concentrations of neopterin, kynurenine and kynurenine/tryptophan ratios predict prognosis and the need for oxygen therapy in patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aims of the present study were to evaluate the changes of these biomarkers early in the course of infection, the association with the prior coronavirus disease (COVID-19) vaccination and therapeutic administration of Anti-SARS-CoV-2 monoclonal antibodies, investigation of other potential biomarkers including neuropilin, 8-hydroxy-2-deoxyguanosine and 8-hydroxyguanosine in patients hospitalized with SARS-CoV-2 infection and an assessment of these biomarkers and vitamins A, E and D in patients with post-COVID syndrome. METHODS: Urine and blood samples were obtained on the 1st to the 4th day and 4th to 7th day from 108 patients hospitalized with COVID-19. Chromatography tandem mass spectrometry methods were used to analyse neopterin, kynurenine, tryptophan, liposoluble vitamins, and DNA damage biomarkers. RESULTS: A statistically significant decrease of neopterin, kynurenine and kynurenine/tryptophan ratios was observed on after 4th to 7th day of hospitalization, and concentrations of these biomarkers were increased in patients with poor prognosis and subsequent post-COVID syndrome. The concentrations of remaining biomarker and vitamins were not associated with outcomes, although markedly decreased concentrations of vitamin A, E and D were noted. CONCLUSIONS: The concentrations of neopterin, kynurenine and kynurenine/tryptophan ratios decrease during the course of infection SARS-CoV-2 and are associated with the post-COVID syndrome. No other prognostic biomarkers were identified.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013865
003      
CZ-PrNML
005      
20240905134036.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2023-1297 $2 doi
035    __
$a (PubMed)38374668
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Krčmová, Lenka Kujovská $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic $1 https://orcid.org/0000000338250294 $7 xx0209338
245    10
$a Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome / $c LK. Krčmová, L. Javorská, K. Matoušová, P. Šmahel, M. Skála, M. Kopecký, C. Suwanvecho, N. Přívratská, D. Turoňová, B. Melichar
520    9_
$a OBJECTIVES: Concentrations of neopterin, kynurenine and kynurenine/tryptophan ratios predict prognosis and the need for oxygen therapy in patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aims of the present study were to evaluate the changes of these biomarkers early in the course of infection, the association with the prior coronavirus disease (COVID-19) vaccination and therapeutic administration of Anti-SARS-CoV-2 monoclonal antibodies, investigation of other potential biomarkers including neuropilin, 8-hydroxy-2-deoxyguanosine and 8-hydroxyguanosine in patients hospitalized with SARS-CoV-2 infection and an assessment of these biomarkers and vitamins A, E and D in patients with post-COVID syndrome. METHODS: Urine and blood samples were obtained on the 1st to the 4th day and 4th to 7th day from 108 patients hospitalized with COVID-19. Chromatography tandem mass spectrometry methods were used to analyse neopterin, kynurenine, tryptophan, liposoluble vitamins, and DNA damage biomarkers. RESULTS: A statistically significant decrease of neopterin, kynurenine and kynurenine/tryptophan ratios was observed on after 4th to 7th day of hospitalization, and concentrations of these biomarkers were increased in patients with poor prognosis and subsequent post-COVID syndrome. The concentrations of remaining biomarker and vitamins were not associated with outcomes, although markedly decreased concentrations of vitamin A, E and D were noted. CONCLUSIONS: The concentrations of neopterin, kynurenine and kynurenine/tryptophan ratios decrease during the course of infection SARS-CoV-2 and are associated with the post-COVID syndrome. No other prognostic biomarkers were identified.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $x krev $7 D000086382
650    12
$a biologické markery $x krev $7 D015415
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a neopterin $x krev $x moč $7 D019798
650    12
$a kynurenin $x krev $7 D007737
650    _2
$a senioři $7 D000368
650    12
$a SARS-CoV-2 $x izolace a purifikace $7 D000086402
650    12
$a tryptofan $x krev $7 D014364
650    _2
$a vitaminy $x krev $7 D014815
650    _2
$a hospitalizace $7 D006760
650    _2
$a dospělí $7 D000328
650    _2
$a postakutní syndrom COVID-19 $7 D000094024
650    _2
$a vitamin A $x krev $7 D014801
650    _2
$a zánět $x krev $7 D007249
650    _2
$a vitamin D $x krev $7 D014807
650    _2
$a vitamin E $x krev $7 D014810
655    _2
$a časopisecké články $7 D016428
700    1_
$a Javorská, Lenka $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Matoušová, Kateřina $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000182835770
700    1_
$a Šmahel, Petr $u Deparment of Infectious Diseases, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Skála, Mikuláš $u Department of Pneumology, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Kopecký, Michal $u Department of Pneumology, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Suwanvecho, Chaweewan $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
700    1_
$a Přívratská, Nikola $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
700    1_
$a Turoňová, Dorota $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Melichar, Bohuslav $u Department of Oncology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
773    0_
$w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 62, č. 6 (2024), s. 1217-1227
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38374668 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134029 $b ABA008
999    __
$a ok $b bmc $g 2143588 $s 1225731
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 62 $c 6 $d 1217-1227 $e 20240221 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...